Ibuprofen Tablet, Film Coated
FDA Label NDC 73614-201

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Brisk Pharmaceuticals for the product Ibuprofen (NDC 73614-201). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

→ Description

→ Package Label.principal Display Panel

Description

Rx Only

NDC 73614-922-03

ClindaCare™

Each Pack Contains:

Clindamycin Hydrochloride Capsules, USP 150 mg - One 30 ct Bottle

Ibuprofen Tablets, USP 800 mg - One 30 ct Bottle

Chlorhexidine Gluconate Oral Rinse, USP 0.12% - Two 118 ml Bottles

Brisk Pharmaceuticals

Packaged by:

Unit Dose Solutions Inc.,

Morrisville, NC 27560

Distributed by:

Brisk pharmaceuticals,

Richardson, TX 75081

Keep out of reach of children.

Storage: Store at 20°C to 25°C

(68°F-77°F).

Lot: See the lot number on each

individual bottle inside the pack.

Exp: See the expiration date on each

individual bottle inside the pack.

Package Label.Principal Display Panel

* Please review the disclaimer below.

Previous Product 73612-201

Next Product 73614-202